Skip to content
Screener

Guardant Health GH Q3 2025 earnings

Reported October 29, 2025 · After market close

Revenue$265.2MMiss by $2.4M
EPS-$0.39Beat by $0.09
Revenue estimate$267.6M
EPS estimate-$0.48

Next report

Oct 28, 2026 (in 2 months)
Revenue estimate$350.1M
EPS estimate-$0.28

Financials

Q3 2025

Income statement

See full
Revenue$265.2M+38.5%
Gross profit$171.6M+46.7%
Operating income-$99.0M+15.6%
Net income-$92.7M+13.9%
EPS (diluted)-$0.74+15.9%

Balance sheet

See full
Cash & equivalents$689.5M+0.2%
Total debt$1.3B+572%
Total equity-$354.5M-490%
Total assets$1.3B-17.0%

Cash flow

See full
Operating cash flow-$35.4M+30.6%
CapEx$10.4M+146%
Free cash flow-$45.8M+17.2%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$7.79B+176%
Enterprise value$8.43B+262%
P/S8.6×+4.6×

Profitability

See full
Gross margin63.8%+4.6pp
Operating margin-49%-12.5pp
Net margin-44.2%-12.7pp
FCF margin-29.1%-6.1pp

Returns & leverage

See full
Current ratio3.5×-2.7×

Segments

By product

See full
Oncology$184.4M+30.6%
Biopharma and data$54.7M+17.6%
Screening$24.1M+2,304%
Licensing and other$2.0M-28.5%

By segment

See full
Reportable Segment$265.2M+38.5%

FAQ

When did Guardant Health report Q3 2025 earnings?
Guardant Health (GH) reported Q3 2025 earnings on October 29, 2025 after market close.
What were Guardant Health's Q3 2025 revenue and EPS?
Guardant Health reported revenue of $265.2M and eps of $-0.39 for Q3 2025.
Did Guardant Health beat estimates in Q3 2025?
Revenue missed the consensus estimate of $267.6M by $2.4M. EPS beat the consensus estimate of $-0.48 by $0.09.
How did Guardant Health's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 38.5% from $191.5M a year earlier and eps grew 13.3% from $-0.45.
Where can I find Guardant Health's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001576280-25-000276) and the 10-Q periodic report (0001576280-25-000277) directly on SEC EDGAR. The filing index links above go to sec.gov.